Gut microbiome study for HIV and hepatitis B
Part of Digestive system, Immune system & allergy, Infections clinical trials.
This study looks at the bacteria in the gut of people with HIV or hepatitis B. You may be asked to provide a stool sample to help researchers understand how these infections affect your microbiome.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older.
- You have HIV and are on antiretroviral therapy, OR you have chronic hepatitis B (with or without cirrhosis or liver cancer).
- You have not taken antibiotics or steroids in the last 24 hours.
- You are not pregnant or breastfeeding at the time of the sample collection.
- You do not have a moderate or severe acute illness (if you do, sampling can be delayed until you recover).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how gut bacteria and inflammation interact in people with both HIV and heavy alcohol use. It aims to find new ways to improve health by understanding these connections.
This study looks at the bacteria in your gut (microbiome) and how your body responds to liver disease. Researchers want to learn if these factors can help improve care for people with liver problems.
This study looks at how changing your HIV medication affects the bacteria in your gut. You'll provide two stool samples so researchers can see what changes happen.
This study looks at tiny cell “messengers” in blood and stool to understand how HIV behaves before and after starting treatment. You may be eligible if you have untreated HIV (or you’re a healthy volunteer) and can commit to many sample visits, including long-term storage for 20 years.
This trial studies how the bacteria in your gut (“microbiome”) relate to frailty (weakness/low physical resilience) in people with HIV who are stably doing well on treatment. It may help researchers understand why some people become frail and how the gut may play a role.
This trial compares how HIV “reservoirs,” inflammation, and the gut microbiome change when people switch from daily HIV pills to long-acting injectable treatment. It may help you and your team understand what to expect with the switch and how your body responds.
Hear when a new Chronic Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.